Buffett Bet Big On This Insurance Stock In 2025 And It Paid Off: Top 10 Berkshire Holding Up $668 Million In 2026

Berkshire added 7,215,399 Chubb shares in 3Q and 4Q 2025 (4,299,111 in 3Q, +16%; 2,916,288 in 4Q, +9%), and those purchases are up $140,772,434.49 in 2026. The Chubb position moved from $7,469,434,000 at end-2024 to $11,358,056,558.30 at the time of writing, a $3,888,622,558.29 gain to Berkshire; CHUBB is +11.5% over 52 weeks and +6.3% YTD 2026. Key near-term catalysts are Chubb's Q1 results in April (could end a six-quarter revenue miss streak despite 11 straight earnings beats) and Berkshire's mid-May 13F filing to clarify stake changes under new CEO Greg Abel.

Analysis

A concentrated, growing ownership base in a large P&C name compresses free float and amplifies price moves on both incremental flows and headline risk; that makes the stock more sensitive to short-term supply-demand imbalances (block trades, options gamma, and index flows) than its fundamentals alone would suggest. Second-order winners include reinsurers and specialty brokers if pricing momentum continues, and conversely regional insurers with weaker balance sheets may see relative outflows as capital chases the perceived safety of scale and underwriting consistency.

Key catalysts live on three horizons: days-to-weeks around the next public reporting and any large institutional filing, months around upcoming commercial-renewal and reinsurance-renewal seasons where rate momentum can flip, and multi-year outcomes driven by reserve development and catastrophe frequency. Tail risks that would reverse the current trend are clear: a large CAT loss or a surprise reserve strengthening that materially compresses underwriting margins, and adverse movement in the investment ledger that removes the float financing advantage.

The consensus narrative leans on continued underwriting outperformance; that is vulnerable to mean reversion because revenue growth has been soft and premium-rate cycles can flip quickly. Positioning that assumes uninterrupted beats underestimates convexity — a prudent tactical approach is to harvest asymmetry via long-dated convex exposure while protecting against headline shocks with either size discipline or explicit hedges tied to catastrophe or insurer-credit spreads.

Key Decisions for Investors

• Long equity (CB): initiate a size-constrained long in CB with a 6-12 month horizon. Target: +30-50% upside if premium momentum and earnings beats persist; Risk control: hard stop at -12% or reduce to half size on a 10% drawdown to protect against CAT/reserve shocks.
• Call option play (CB): buy 12–18 month long-dated calls (e.g., Jan–Dec 2027 expiries) to capture re-rating with defined downside (premium). Risk/reward: limited put-like loss (100% premium) for potential 2–4x returns if underwriting/earnings surprise to the upside.
• Pair trade (long CB / short TRV or HIG): 0.6x notional short a peer to neutralize macro-catastrophe beta and isolate idiosyncratic outperformance. Timeframe 3–9 months; expected payoff if market rotates to larger-scale specialty underwriters. Risk: correlated CAT event will hurt both legs—size and correlation stress tests required.
• Event hedge: buy protective insurance-sector CDS or short-dated puts on CB around major filings and the next earnings release to limit headline risk over the 2–6 week window. Cost judged against the value of avoiding a >12% drawdown from a surprise reserve/CAT outcome.
• Portfolio-level: reduce gross exposure elsewhere to keep net insurance exposure stable if adding CB (or alternatively add BRK.B as a defensive hedge). Rationale: ownership concentration and float-driven volatility raise idiosyncratic tail risk; maintain liquidity to exploit any large, transient dislocations.